Marketplace

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Business

Cancer, Oncology, start-up, Europe, Investment fund

ALCEA ADVISORS, the Reference Partner for Oncology Startups in Europe, Welcomes Patrick Langlois as a Partner to Its Leadership Team and Chairman to Its Strategic Investors Advisory Committee

ALCEA ADVISORS welcomes Patrick Langlois as a Partner to its Leadership Team and Chairman to its Strategic Investors Advisory Committee

Medicine

Business

Channels:

Cancer, Venture Capital, Venture Partners, Oncology, start-up, Europe, Investment fund, Life Sciences, Healthcare, Investment, Entrepeneur, Health

ALCEA ADVISORS, the Reference Partner for Oncology Startups in Europe, Expands Its Leadership Team with Dr. Jacques-Pierre Moreau and Dr. Nuno Arantes-Oliveira Joining as Venture Partners

ALCEA ADVISORS adds world class entrepreneurial and translational talent to continue to deliver on its vision to back the boldest entrepreneurs in the oncology space in Europe

Business

Channels:

Chicago Booth and Nielsen Expand Relationship

The University of Chicago Booth School of Business and Nielsen, the global measurement and analytics company, have expanded their ongoing collaboration with the availability of a new dataset from Nielsen’s Ad Intel Data.

Life

Arts and Humanities

Channels:

Northwestern University, Book, Economics, Humanities, Morton Schapiro

New Book Calls for Putting More Humanities Into Economics

In a passionately argued new book, Northwestern University literary scholar Gary Saul Morson and Northwestern President Morton Schapiro make the claim that economics is missing its humanity, and economists must look to literature to make their research work in the real world.

Medicine

Channels:

MD Anderson and Convergent R.N.R. Ltd. Establish Alliance to Further Develop New Radiation Technology with Potentially Fewer Side Effects

The University of Texas MD Anderson Cancer Center and Convergent R.N.R. Ltd. (CRnR) today announced a collaboration to further develop new radiation technology aimed at reducing side effects of standard radiation including unwanted radiation to healthy tissue.

Science

Business

Channels:

food coloring, Avocado

Penn State Food Scientist Turns Avocado Pits Into Natural Food Coloring

avocolor-ziegler.jpg.png

A multiyear research endeavor led a Penn State food scientist to form a natural food coloring company based on avocado pits.

Medicine

Business

Channels:

tyrosine kinase inhibitor, Neurogenerative, neurogenerative diseases, Clinical Trial, Autophagy, Parkinson's Disease

Georgetown University Licenses Use of Tyrosine Kinase Inhibitors for Treatment of Neurodegenerative Diseases

Georgetown University today announces it has exclusively licensed worldwide intellectual property (IP) rights to develop and commercialize uses of tyrosine kinase (TK) inhibitors for the treatment of neurodegenerative diseases to Axovant Sciences GmbH.

Medicine

Business

Channels:

Helen Woldeab, Hartley Thompson, B-Line Medical, B-line, simcapture, SimCapture Ultaportable, SimCaptureNode, Livecapture, nursing simulation, Nursing, National Council of State Boards of Nursing , NYU, NYU College of Nursing, University of the sunshine coast, Oregon Health & Science University, Hospial

Nursing Programs Now Represent 25% of B-Line Medical’s Clientele

B-Line Medical is pleased to announce their 100th nursing program client. B-Line Medical’s flagship product, SimCapture, provides a turnkey solution to manage and operate all types of healthcare simulation centers, including nursing education programs.

Medicine

Channels:

Mercy Medical Center in Baltimore Launches Awareness Campaign to Inform Community About Importance of Hepatitis C Screening

thuluvath.endoscopysuite1.102015.jpg

World-renown hepatologist Dr. Paul J. Thuluvath of Mercy Medical Center in Baltimore, MD, encourages the Maryland health care community to raise awareness about the importance of hepatitis C screening in light of recent CDC recommendations about the disease.

Medicine

Channels:

immunotheraphy, Chemotherapy, Immunochemotherapy, Life Sciences Biotechnology, Tumor, Glioblastoma, T Cells, gamma delta T cells, Biopharmaceutical, Cancer

UAB Spinoff Targets Cancer with Drug-Resistant Immunotherapy, a Novel Approach to Fighting Tumors

RS17534_LarryLamb-WillHo-7-scr.jpg

The University of Alabama at Birmingham and two partner institutions have received a European patent for their novel approach to fighting cancer, an approach that is led by the UAB spinoff biopharmaceutical company Incysus Ltd.







Chat now!